BioSig Technologies (BSGM)
BSGM
Cardiac EP
BiotechSign Signal Grade
F
Signal Grade
0.9/100 composite signal score
Composite of clinical trial activity, dilution exposure, publications, short interest, and insider transactions — all from verified public filings.
Insider Buying
0
Publications
70
Clinical Activity
0
Pipeline Overview
- Therapeutic Focus
- Cardiac EPsrc
Clinical Trial Activity
0
Clinical Trials
(ClinicalTrials.gov aggregate)
(ClinicalTrials.gov aggregate)
5
PubMed Publications
0
Catalyst Records
ClinicalTrials.gov aggregate as of 2026-10-13. ClinicalTrials.gov
Recent News & SEC Filings
- SEC 8-K 8-K - Current report
- SEC 8-K 8-K - Current report
- SEC 8-K 8-K - Current report
- SEC 8-K 8-K - Current report
- SEC 8-K 8-K - Current report
Headlines from public sources. BiotechSign does not endorse or verify linked content.
Recent Publications
- Ultra-Low Cryoablation for Scar-Related VT Ablation: Results From the US Early Feasibility Study. — Circ Arrhythm Electrophysiol 2026 Feb PMID 41623095
- Pulsed-Field Ablation to Enhance the Durability of Pulmonary Vein Isolation and Treat Paroxysmal Atrial Fibrillation. — J Am Coll Cardiol 2026 Apr 14 PMID 41563170
- Premature Ventricular Complexes After Ablation for Paroxysmal Atrial Fibrillation and Recurrent Atrial Arrhythmias: The admIRE Subanalysis. — JACC Clin Electrophysiol 2025 Aug PMID 40439651
- Safety and effectiveness of the first balloon-in-basket pulsed field ablation system for the treatment of atrial fibrillation: VOLT CE Mark Study 6-month results. — Europace 2025 Mar 28 PMID 40163671
- Operator learning curve with a novel dual-energy lattice-tip ablation system. — Heart Rhythm 2026 Jan PMID 39922404
Get real-time catalyst alerts, analyst signals, dilution risk tracking, and full pipeline data for BioSig Technologies.
Full BSGM Dashboard Sign Up FreePrimary Sources
This page reports only records present in the BiotechSign source payload as of the generation date. It does not infer drug efficacy, clinical outcome probability, approval odds, revenue, market size, or unreported regulatory events.